Free Trial

Outset Medical (OM) Competitors

Outset Medical logo
$14.18 +0.01 (+0.07%)
Closing price 09/19/2025 04:00 PM Eastern
Extended Trading
$14.38 +0.20 (+1.41%)
As of 09/19/2025 06:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OM vs. INMD, IRMD, EMBC, TNDM, AXGN, SIBN, BVS, AVNS, ZIMV, and KIDS

Should you be buying Outset Medical stock or one of its competitors? The main competitors of Outset Medical include InMode (INMD), iRadimed (IRMD), Embecta (EMBC), Tandem Diabetes Care (TNDM), AxoGen (AXGN), SiBone (SIBN), Bioventus (BVS), Avanos Medical (AVNS), ZimVie (ZIMV), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry.

Outset Medical vs. Its Competitors

Outset Medical (NASDAQ:OM) and InMode (NASDAQ:INMD) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, media sentiment, earnings and institutional ownership.

In the previous week, InMode had 3 more articles in the media than Outset Medical. MarketBeat recorded 4 mentions for InMode and 1 mentions for Outset Medical. Outset Medical's average media sentiment score of 1.77 beat InMode's score of 0.84 indicating that Outset Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Outset Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
InMode
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Outset Medical has a beta of 2.13, indicating that its share price is 113% more volatile than the S&P 500. Comparatively, InMode has a beta of 2, indicating that its share price is 100% more volatile than the S&P 500.

68.0% of InMode shares are owned by institutional investors. 2.4% of Outset Medical shares are owned by insiders. Comparatively, 6.9% of InMode shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Outset Medical presently has a consensus target price of $24.67, suggesting a potential upside of 73.95%. InMode has a consensus target price of $18.04, suggesting a potential upside of 22.73%. Given Outset Medical's stronger consensus rating and higher possible upside, analysts clearly believe Outset Medical is more favorable than InMode.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Outset Medical
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00
InMode
0 Sell rating(s)
7 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.13

InMode has higher revenue and earnings than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Outset Medical$113.69M2.22-$127.98M-$20.29-0.70
InMode$394.82M2.35$181.27M$2.475.95

InMode has a net margin of 44.50% compared to Outset Medical's net margin of -82.06%. InMode's return on equity of 18.38% beat Outset Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Outset Medical-82.06% -97.17% -32.84%
InMode 44.50%18.38%16.35%

Summary

InMode beats Outset Medical on 11 of the 16 factors compared between the two stocks.

Get Outset Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OM vs. The Competition

MetricOutset MedicalMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$251.75M$2.23B$5.79B$10.40B
Dividend YieldN/AN/A5.63%4.60%
P/E Ratio-0.7037.9680.5826.78
Price / Sales2.2211.33534.22123.54
Price / CashN/A59.6437.9961.55
Price / Book1.8911.7215.776.40
Net Income-$127.98M-$64.84M$3.30B$271.80M
7 Day Performance3.58%1.21%5.36%3.48%
1 Month Performance6.30%4.81%8.10%9.90%
1 Year Performance64.92%34.70%81.36%28.44%

Outset Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OM
Outset Medical
2.2031 of 5 stars
$14.18
+0.1%
$24.67
+74.0%
+59.1%$251.75M$113.69M-0.70520Positive News
INMD
InMode
2.8115 of 5 stars
$14.86
+0.2%
$18.04
+21.4%
-17.1%$937.39M$394.82M6.02480Positive News
IRMD
iRadimed
4.8145 of 5 stars
$71.61
+0.5%
$72.00
+0.5%
+43.2%$906.20M$73.24M44.20110News Coverage
Insider Trade
Short Interest ↓
EMBC
Embecta
4.4545 of 5 stars
$15.08
+0.5%
$19.00
+26.0%
-8.7%$877.86M$1.12B10.552,100Positive News
TNDM
Tandem Diabetes Care
4.2697 of 5 stars
$12.09
-1.5%
$22.44
+85.6%
-71.7%$829.08M$940.20M-3.912,650Positive News
AXGN
AxoGen
2.8621 of 5 stars
$16.37
-0.2%
$26.00
+58.8%
+17.2%$755.07M$187.34M-163.68450Positive News
SIBN
SiBone
3.8047 of 5 stars
$15.14
-3.6%
$23.67
+56.3%
-7.8%$677.31M$185.26M-27.04350Positive News
BVS
Bioventus
N/A$7.17
-0.8%
N/AN/A$597.77M$573.28M14.461,200
AVNS
Avanos Medical
1.7544 of 5 stars
$12.28
+0.5%
N/A-51.7%$567.03M$692.50M-1.222,227
ZIMV
ZimVie
1.3894 of 5 stars
$18.89
+0.1%
$17.75
-6.0%
+11.5%$532.34M$449.75M-26.991,770Positive News
KIDS
OrthoPediatrics
4.3739 of 5 stars
$19.56
-0.5%
$34.14
+74.6%
-34.3%$492.70M$204.73M-10.93200Positive News

Related Companies and Tools


This page (NASDAQ:OM) was last updated on 9/20/2025 by MarketBeat.com Staff
From Our Partners